phase i study of cart-ddbcma in r/r multiple myeloma
Published 2 years ago • 284 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
3:18
phase i study of cart-ddbcma in r/r multiple myeloma
-
0:53
follow-up from a phase i study of cart-ddbcma for the treatment of r/r multiple myeloma
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
3:06
phase i study of hpn217 in patients with r/r multiple myeloma
-
24:46
sumit verma of iovance biotherapeutics - 1 time therapy for solid tumors
-
5:00
rouleaux formation | peripheral blood smear examination | hematology | multiple myeloma| esr |
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
1:21
sequencing of bcma-directed therapies for multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
1:01
car-t: myeloma toxicities
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
2:44
myeloma qol through induction and maintenance
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:27
car-t cells in myeloma
-
2:42
results of phase i/ii study of epcoritamab r-dhax/c in patients with r/r dlbcl eligible for autosct